Chronic diseases, including metabolic diseases, have become a worldwide public health
issue. Research regarding the use of bioactive peptides or protein hydrolysates derived from …

Alzheimer's disease (AD) is a neurodegenerative disease with high prevalence in the
rapidly growing elderly population in the developing world. The currently FDA approved …

The remarkable growth of therapeutic peptide development in the past decade has led to a
large number of market approvals and the market value is expected to hit $25 billion by …

The maintenance of the body weight at a stable level is a major determinant in keeping the
higher animals and mammals survive. The body weight depends on the balance between …

Recent preclinical and clinical studies have indicated that the galanin peptide family may
regulate glucose metabolism and alleviate insulin resistance, which diminishes the …

Despite the established comorbidity between mood disorders and abnormal eating
behaviors, the underlying molecular mechanism and therapeutics remain to be resolved …

Obesity/overweight are important health problems due to metabolic complications.
Dysregulation of peptides exerting orexigenic/anorexigenic effects must be investigated in …

The regulatory (neuro) peptide galanin is widely distributed in the central and peripheral
nervous systems, where it mediates its effects via three G protein-coupled receptors (GAL 1 …

Ischemic stroke-induced neuronal cell death results in the permanent disabling of brain
function. Apoptotic mechanisms are thought to play a prominent role in neuronal injury and …

Neuromedin U (NMU) belongs to a family of multifunctional neuropeptides that modulate the
activity of several neural networks of the brain. Acting via metabotropic receptor NMUR2 …